Market Overview - The personal care products sector rose by 2.89% on September 4, with Jieya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3765.88, down 1.25%, while the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Stock Performance - Jieya Co., Ltd. (301108) closed at 34.40, up 13.16% with a trading volume of 72,700 shares and a turnover of 243 million yuan [1] - Yiyi Co., Ltd. (001206) closed at 26.72, up 10.00% with a trading volume of 131,800 shares and a turnover of 342 million yuan [1] - Dengkang Oral Care (001328) closed at 43.55, up 7.40% with a trading volume of 53,000 shares and a turnover of 226 million yuan [1] - Other notable performers include Ziya Co., Ltd. (003006) up 5.13%, and Liangmian Needle (600249) up 3.29% [1] Capital Flow - The personal care products sector saw a net inflow of 56.24 million yuan from institutional investors, while retail investors experienced a net outflow of 6.89 million yuan [2] - The main capital inflow was observed in Yiyi Co., Ltd. with 64.76 million yuan, while the largest outflow was from Jieya Co., Ltd. with 22.08 million yuan [3] Individual Stock Analysis - Jieya Co., Ltd. had a main capital inflow of 3.69 million yuan, but retail investors showed a net outflow of 22.07 million yuan [3] - Dengkang Oral Care experienced a net outflow of 4.13 million yuan from main capital, while retail investors had a net inflow of 14.52 million yuan [3] - Ziya Co., Ltd. had a net inflow of 3.36 million yuan from main capital, with a slight outflow from retail investors [3]

中海消费混合A（398061）基金经理为何文逸。 截至发稿，何文逸累计任职时间3年203天，现任基金资产总规模3.03亿元，任职期间最佳基金回报 28.32%， 任职期间最差基金回报-32.34%。 资料显示，重庆登康口腔护理用品股份有限公司位于重庆市江北区海尔路389号，成立日期2001年12月 14日，上市日期2023年4月10日，公司主营业务涉及从事口腔护理用品的研发、生产与销售。主营业务 收入构成为：成人牙膏80.43%，成人牙刷9.90%，儿童牙膏4.54%，口腔医疗与美容护理产品等2.44%， 儿童牙刷1.76%，电动牙刷0.81%，其他(补充)0.11%。 从基金十大重仓股角度 数据显示，中海基金旗下1只基金重仓登康口腔。中海消费混合A（398061）二季度增持1.54万股，持有 股数21.2万股，占基金净值比例为4.64%，位居第四大重仓股。根据测算，今日浮盈赚取约44.52万元。 中海消费混合A（398061）成立日期2011年11月9日，最新规模2.23亿。今年以来收益11.13%，同类排名 5315/8180；近一年收益19.69%，同类排名5668/7978；成立以来收益287.67% ...

9月4日，登康口腔涨5.18%，截至发稿，报42.65元/股，成交1.08亿元，换手率6.05%，总市值73.43亿 元。 资料显示，重庆登康口腔护理用品股份有限公司位于重庆市江北区海尔路389号，成立日期2001年12月 14日，上市日期2023年4月10日，公司主营业务涉及从事口腔护理用品的研发、生产与销售。主营业务 收入构成为：成人牙膏80.43%，成人牙刷9.90%，儿童牙膏4.54%，口腔医疗与美容护理产品等2.44%， 儿童牙刷1.76%，电动牙刷0.81%，其他(补充)0.11%。 从基金十大重仓股角度 数据显示，南华基金旗下1只基金重仓登康口腔。南华瑞盈混合发起A（004845）二季度持有股数2.42万 股，占基金净值比例为3.32%，位居第六大重仓股。根据测算，今日浮盈赚取约5.08万元。 南华瑞盈混合发起A（004845）成立日期2017年8月16日，最新规模2401.18万。今年以来收益1.01%， 同类排名7747/8180；近一年收益28.8%，同类排名4635/7978；成立以来收益35.6%。 南华瑞盈混合发起A（004845）基金经理为徐超、陆越。 截至发稿，徐超累计任职时间9 ...

多家黄金珠宝品牌金价直破千元，周大福报价1037元/克，周六福报1023元/克，潮宏基1037元/克。 高昂的金价让消费者望而却步，但与之形成鲜明对照的，是十几天前老铺黄金宣布提价，多个城市的老铺黄金门前再度排起长队。 金价高企，黄金珠宝上市企业的悲喜却并不相通。老铺黄金高客单、高坪效的"奢侈品叙事"只是个例，更多品牌拿到的是关店止损、转战线 上、押注IP联名挖掘高溢价的"求生"剧本。 9月2日，现货黄金盘中突破3500美元/盎司，创历史新高，截至北京时间22:50，最新报价3508美元/盎司。 在老铺黄金独自狂欢之际，集体性落寞开始在黄金珠宝圈儿悄悄上演。 记者丨张晓慧 编辑丨朱益民 周六福们逆境求存 金价居高不下，几家欢喜几家愁。一边是老铺黄金凭借几十家店铺半年做出百亿营收；另一边，也有黄金珠宝企业在"断臂求生"，战略转型。 中国黄金协会统计数据显示，2025年上半年，我国黄金消费量505.205吨，同比下降3.54%。其中，黄金首饰199.826吨，同比下降26%。 老铺黄金，还在排队 今年8月，老铺黄金进行年内第二次提价，涨价前日，上海、北京、成都等多地老铺黄金重现"排队潮"。老铺黄金的"奢侈品叙事" ...

证券之星消息，9月2日重庆国企改革板块较上一交易日下跌1.11%，*ST惠程领跌。当日上证指数报收于 3858.13，下跌0.45%。深证成指报收于12553.84，下跌2.14%。重庆国企改革板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600689 | 上海三毛 | 13.79 | 2.99% | 10.02万 | 1.36亿 | | 601158 | 重庆水务 | 4.74 | 0.64% | 15.63万 | 7368.78万 | | 000565 | 渝三峡A | 8.71 | 0.23% | 18.26万 | 1.58 Z | | 601827 | 三峰环境 | 8.54 | 0.00% | 1 5.34万 | 4543.59万 | | 600939 | 車庆建工 | 3.49 | -0.29% | 10.20万 | 3545.34万 | | 000950 | 重药控股 | 5.23 | -0.38% | 22.84万 | 1.19亿 | | 600369 | ...

Summary of the Conference Call for Dengkang Oral Care Company Overview - **Company**: Dengkang Oral Care - **Industry**: Oral Care Products Key Points and Arguments Sales Performance - In Q2, online channel sales decreased month-over-month due to strategic adjustments but still showed year-over-year growth. The offline channel benefited from the promotion of the "7-Day Repair Toothpaste," leading to significant sales growth. The company expects to achieve over 50% channel distribution in Q3 and aims for 90% by year-end [2][5] - The "7-Day Repair Toothpaste" has a gross margin approximately 30% higher than other toothpastes, with a net profit margin improvement of over ten percentage points, targeting sensitive and high-income consumers in major cities [2][8] New Product Launches - The new "Keratin Toothpaste," launched in August 2025, has shown excellent performance within two weeks, with the company aiming to leverage this product to drive e-commerce growth, particularly on platforms like Douyin [6][18] - The company plans to increase the proportion of mid-to-high-end products to enhance profitability, with a target of achieving over 10% market share in 2025 and 15%-20% in 2026 for offline sales [7][11] E-commerce Strategy - The e-commerce strategy focuses on high-quality development, reducing traffic spending on Douyin while maintaining a natural growth rate of 20%-30%. The company emphasizes strengthening warehousing and shelf e-commerce, particularly on profitable platforms like Tmall and JD [13][14] - In H1 2025, the overall e-commerce profitability remained stable compared to the previous year, with Douyin showing slight improvements in net profit margin [16] Market Position and Competition - Dengkang Oral Care aims to become the second-largest player in the industry within three years and to narrow the gap with the market leader within five years, contingent on maintaining growth trends and no significant issues with competitors [3][24] - The company has seen its market share in the offline segment grow from over 8% in 2024 to nearly 10% in 2025, while competitors are experiencing declines [22][25] Future Outlook - The company anticipates a significant improvement in offline profitability by 2026, while online profitability may improve due to adjustments in traffic costs [17] - Dengkang Oral Care plans to focus on promoting the "Keratin Toothpaste" and gradually introduce higher-end products, adapting to market conditions and consumer acceptance [19][20] Financial Metrics - The gross margin for the "Keratin Toothpaste" is estimated to be between 80% and 90%, higher than previous products [21] - Online sales accounted for approximately 35%-36% of total revenue in H1 2025, with expectations to reach around 40% in the following year [28] Additional Insights - The company has launched 15 new products in 2025, with a focus on the "Keratin Toothpaste" and "Huanglian Toothpaste," targeting different market segments [18] - The competitive landscape in e-commerce is challenging, with competitors facing losses, while Dengkang maintains a focus on stable profitability despite slower growth [22] This summary encapsulates the key insights from the conference call, highlighting Dengkang Oral Care's strategic initiatives, market performance, and future outlook in the oral care industry.

证券研究报告 | 公司点评 | 个护用品 线上为核心驱动，关注后续医研新品催化 ——登康口腔 2025H1 业绩点评报告 投资要点 ❑ 登康口腔披露 2025H1 业绩： 2025H1 公司实现营业收入 8.4 亿元，同比+19.7%，实现归母净利润 0.9 亿元，同 比+17.6%，扣非后归母净利润 0.7 亿元，同比+25.7%；25Q2 单季公司实现营业 收入 4.1 亿元，同比+20.1%，实现归母净利润 0.42 亿元，同比+19.7%，扣非后归 母净利润 0.34 亿元，同比+24.0%。公司 Q2 增长靓丽，业绩表现略超我们预期。 ❑ 线下渠道相对稳定，线上渠道持续高增 分产品：2025H1 公司成人牙膏业务实现营业收入 6.8 亿元，同比+23.0%，销售 占比提升至 80%；成人牙刷业务实现收入 0.8 亿元，同比+4.2%，销售占比约为 10%。成人牙膏业务表现优异。 分渠道：2025H1 公司线下渠道实现收入 5.4 亿元，同比-0.2%，销售占比约为 64%，仍为公司收入主要来源。其中经销/直供渠道收入分别为 5.1/ 0.2 亿元，分 别同比-0.5%/ +13.6%；2025H1 ...

Market Overview - The personal care products sector experienced a decline of 1.87% on September 1, with Haoyue Care leading the drop [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] Stock Performance - Notable stock performances include: - Yiyi Co., Ltd. (001206) closed at 25.98, up 2.81% with a trading volume of 91,800 shares and a turnover of 238 million yuan [1] - Haoyue Care (605009) closed at 36.35, down 10.00% with a trading volume of 111,800 shares and a turnover of 408 million yuan [2] - Zhongshun Jierou (002511) closed at 8.64, down 1.48% with a trading volume of 186,900 shares and a turnover of 162 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 147 million yuan from institutional investors, while retail investors experienced a net inflow of 98.24 million yuan [2] - The capital flow for individual stocks shows: - Ziya Co., Ltd. (003006) had a net inflow of 6.03 million yuan from institutional investors [3] - Haoyue Care (605009) had a significant net outflow of 622.31 million yuan from institutional investors [3]

Core Viewpoint - In Q2 2025, the company achieved a revenue growth of 20.1% year-on-year and a net profit growth of 19.7%, driven by the increasing proportion of high-margin medical research products [1][3] - The adult toothpaste segment led the growth in H1 2025, with a focus on the "Medical Research 7-Day Repair Toothpaste" and a significant online sales presence, particularly on Douyin [1][4] - E-commerce sales surged by 81.13% year-on-year, accounting for 38.62% of total revenue, while offline channel revenue remained stable [1][5] Financial Performance - For H1 2025, the company reported a revenue of 842 million yuan, up 19.7%, and a net profit of 85 million yuan, up 17.6%, with a basic EPS of 0.49 yuan [2] - In Q2 2025, revenue reached 411 million yuan, reflecting a 20.1% increase, and net profit was 42 million yuan, up 19.7% [3] Product Performance - Adult toothpaste revenue in H1 2025 was 677 million yuan, growing by 23%, with a gross margin of 53.59% [4] - New product launches in the adult toothpaste category included high-end variants, contributing to a significant increase in the share of mid-to-high-end products [4] - Emerging categories such as electric toothbrushes and oral healthcare products saw substantial growth, with electric toothbrush revenue increasing by 37.33% [4] Channel Performance - E-commerce and other channels generated 325 million yuan in H1 2025, marking an 81.13% increase, while offline channel revenue was stable at 516 million yuan [5] - The company leveraged Douyin to expand online presence, which positively impacted offline sales as well [5] Cost and Profitability - The gross margin for H1 2025 was 52.61%, up 5.68 percentage points, primarily due to the higher revenue share from high-margin products [6] - The net profit margin for H1 2025 was 10.12%, indicating stable profitability despite increased marketing expenses [7] Future Outlook - Revenue projections for 2023-2025 are 1.89 billion, 2.27 billion, and 2.69 billion yuan, with expected growth rates of 21.0%, 20.3%, and 18.3% respectively [7] - The company anticipates continued growth in net profit, with estimates of 203 million, 255 million, and 308 million yuan for the same period [7]

Core Viewpoint - The company reported a strong performance in the first half of 2025, with revenue and net profit showing significant year-on-year growth, indicating a positive outlook for the business. Financial Performance - In H1 2025, the company achieved revenue of 842 million, a year-on-year increase of 19.7%, and a net profit attributable to shareholders of 85 million, up 17.6% [1] - Q2 2025 revenue reached 411 million, reflecting a 20.1% increase year-on-year, with net profit of 42 million, a 19.7% increase [1] - The company's net profit margin for H1 2025 was 10.12%, a slight decrease of 0.18 percentage points year-on-year [3] Revenue Breakdown - Adult toothpaste, which accounted for 80% of total revenue, saw a 23% increase in revenue [2] - Emerging oral care products generated revenue of 20 million, growing by 54.85% [2] - Electric toothbrush sales reached 6.816 million, a year-on-year increase of 37.33% [2] - E-commerce channel revenue surged to 325 million, a significant growth of 81.13%, increasing its share of total revenue from 25.53% to 38.62% [2] - Offline channel revenue was 517 million, showing a slight decline of 1.3% [2] Cost Structure and Profitability - The gross margin for H1 2025 was 52.61%, an increase of 5.68 percentage points year-on-year [3] - The sales expense ratio rose to 36.5%, up 6.3 percentage points, primarily due to increased investment in e-commerce and product upgrades [3] - Management, R&D, and financial expense ratios were 3.38%, 3.1%, and -0.7%, respectively, with management and R&D expenses decreasing year-on-year [3] Investment Outlook - The company maintains a stable offline channel while driving rapid growth in online channels through high-margin products [4] - The projected net profits for 2025-2027 are 204 million, 246 million, and 293 million, with year-on-year growth rates of 26.7%, 20.3%, and 19.4% respectively [4] - The current valuation corresponds to multiples of 37x, 31x, and 26x for the respective years [4]